COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes
Vivienne Kahlmann(Erasmus MC), Nadera Sweiss(University of Illinois Chicago), Michael Manansala, Marlies Wijsenbeek(Erasmus University Rotterdam), Shiva Shahrara(University of Illinois Chicago), Catharina C. Moor(Erasmus MC)
Cited by 10
Related Papers
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Racial Difference in Sarcoidosis Mortality in the United States
|CHEST Journal|2014|251
Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction
|Circulation Cardiovascular Imaging|2016|217